Hogan Lovells Expands Baltimore Office With Health and Insurance Partner Therese Goldsmith
17 September 2015
BALTIMORE, MD 17 September 2015 – Hogan Lovells is pleased to announce that former Maryland Insurance Commissioner Therese Goldsmith has joined the Health practice and the Insurance Industry sector group as a partner in the Baltimore office.
In addition to serving as Maryland Insurance Commissioner, Goldsmith was a Commissioner on the Maryland Public Service Commission, where she was responsible for regulating public utilities. Prior to that, Goldsmith was a White Collar Litigation partner at Hogan & Hartson, a predecessor firm of Hogan Lovells.
While serving as Maryland Insurance Commissioner, Goldsmith played a key role in the state’s implementation of the Affordable Care Act. She also held leadership positions with the National Association of Insurance Commissioners, the U.S. standard-setting and regulatory support organization governed by chief insurance regulators from the 50 states, the District of Columbia and five U.S. territories. She served as the 2014 Vice Chair of the NAIC’s Market Regulation and Consumer Affairs Committee and the NAIC's Market Actions Working Group. She also chaired the NAIC's Market Regulation Accreditation Working Group and represented the NAIC at the Cybersecurity Forum for Independent and Executive Branch Regulators.
“Therese’s extensive experience in insurance regulation, health care and white collar litigation makes her an excellent strategic fit for our team,” said Sheree Kanner, global head of Hogan Lovells’ health practice. “She is a proven, collaborative, and esteemed attorney and we are delighted to welcome her back to Hogan Lovells.”
Goldsmith’s practice will focus on insurance regulatory matters and healthcare issues. In regard to the Insurance practice, she will provide strategic support in corporate transactions, insurance M&A and financing transactions, restructuring of insurance groups, demutilizations, insurance insolvencies, regulatory investigations, and legislative initiatives, among others. With the Health group, she will advise health insurance issuers regarding compliance with the Affordable Care Act and other governing laws and regulations, represent healthcare clients in connection with fraud and abuse matters, and assist in developing compliance plans and conducting internal audits and investigations. Goldsmith also will utilize her experience with health information privacy and security issues.
“Therese’s demonstrated commitment to client service, her strength in organizing and running an interdisciplinary team, and her exceptional legal skills will greatly benefit our Health and Insurance Industry sector practices,” said Alice Valder Curran, regional managing partner for Hogan Lovells’ Washington, D.C., Baltimore, Northern Virginia, and Philadelphia offices. “Furthermore, Therese’s experience with local issues and procedures stemming from her work with Maryland’s Insurance Administration and Public Service Commission will be invaluable for our regional clients.”
Active in the community, Goldsmith has provided pro bono legal representation through the American Civil Liberties Union and the Maryland Disability Law Center. She has also served on the Ascension School Board and the Governor’s Information Technology Board (Health Care and the Internet Subcommittee). Goldsmith is admitted to practice law in Maryland.
Goldsmith earned her B.S. and M.S. from Towson University. She received her J.D. from the University of Maryland School of Law.
Hogan Lovells has one of the largest and most experienced health practices in the nation, providing advice across the full range of health issues including fraud and abuse, coverage and reimbursement, health reform, regulatory compliance, litigation, mergers and acquisitions and health information technology. Hogan Lovells also has one of the leading global practices in the insurance sector, in both the non- contentious and contentious areas. The firm assists clients both large and small including insurance and reinsurance companies, health care systems, hospitals and other providers, pharmaceutical and medical device manufacturers, and health information technology companies.